Daniel M. Junius - 17 May 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role: Director
Signature: /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
Issuer symbol: IDXX
Transactions as of: 17 May 2023
Net transactions value: $0
Form type: 4
Filing time: 19 May 2023, 17:02:50 UTC
Previous filing: 11 May 2023
Next filing: 22 May 2023
SEC: View on sec.gov

Key filing fact

Daniel M. Junius filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 19 May 2023.

Key facts

This page summarizes Daniel M. Junius's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
2 reported transactions and 2 derivative rows are listed below.
Filing timestamp: 19 May 2023, 17:02.

Change

Previous filing in this sequence was filed on 11 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

IDXX transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Award

Transaction value: $0
Shares: +645
Change %
Price: $0.000000
Shares after: 645
Date: 17 May 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 645
Exercise price: $487.12
Footnotes: F1

IDXX transaction Derivative

Deferred Stock Unit

Award

Transaction value
Shares: +257
Change %: +75%
Price
Shares after: 601
Date: 17 May 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 257
Exercise price
Footnotes: F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier.
F2	Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.

Content

Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier.

Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.